Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2025 12:55 ET | Source: Bernstein Liebhard LLP

REGENERON THERAPEUTICS, INC. (NASDAQ: REGN) INVESTOR ALERT: Investors With Large Losses in Regeneron Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

REGENERON THERAPEUTICS, INC. (NASDAQ: REGN) INVESTOR ALERT: Investors With Large Losses in Regeneron Therapeutics, Inc. Should Contact Bernstein Liebhard
November 05, 2015 07:30 ET | Source: Repligen Corporation

Repligen Reports Third Quarter 2015 Financial Results

- Product Sales Increase 31% to $19.8 Million - - Conference Call and Webcast Today at 8:30 a.m. ET - WALTHAM, Mass., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a...